Antiretroviral theapy for HIV prevention | Consultation | 2-4 November 2009 | Geneva, Switzerland

WHO hosted a consultation on antiretroviral therapy (ART) for HIV prevention on 2-4 November 2009. This meeting followed the publication in The Lancet of a mathematical model on ART for HIV prevention developed by WHO scientists.

The meeting brought together a broad range of stakeholders: researchers, health economists, modellers, policy and programme planners, civil society representatives, people living with HIV, gender advocates, human right experts and ethicists, cosponsors of UNAIDS, donors and bilateral agencies.

The aim of the consultation was to discuss broad issues around the concept of ART for HIV prevention, including feasibility and acceptability, human rights and ethical implications, and research priorities.

Consultation agenda and presentations

Modelling the impact of antiretroviral therapy on TB and HIV

Informal working group meeting | 4-6 November

WHO authored article featured in The Lancet

An ART for prevention article appeared in The Lancet journal in November 2008.

Universal voluntary HIV testing with immediate antiretroviral theapy as an approach for elimination of HIV transmission: a mathematical model

Reference articles


Key publications

Towards universal access

Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report, September 2009

Scaling up priority HIV/AIDS interventions in the health sector
Progress report, September 2009

Priority interventions

HIV/AIDS prevention, treatment and care in the health sector

Email us at or fill in our feedback form.